Literature DB >> 3053889

Causality assessment of drug-induced liver injury. Hepatology Working Group.

G Danan1.   

Abstract

None of the various methods for drug reaction assessment has been adapted to the well-defined damage of a specific organ. There are disagreements between the parties involved in this issue: practitioners, and experts in drug surveillance either in regulatory agencies or in the pharmaceutical industry. Consensus Meetings were therefore organized in order to answer the three basic questions related to the diagnosis of drug-induced liver injury: (a) is the liver involved? (b) what chronological and clinical criteria suggest a drug-induced reaction? (c) can non-drug-related causes be excluded? On the basis of the method for drug reaction assessment used in France, we describe criteria adapted to the case of acute cytolytic hepatitis, which constitutes only one aspect of the task of the Hepatology Working Group.

Entities:  

Mesh:

Year:  1988        PMID: 3053889     DOI: 10.1016/s0168-8278(88)80517-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  18 in total

1.  Accuracy of hepatic adverse drug reaction reporting in one English health region.

Authors:  G P Aithal; M D Rawlins; C P Day
Journal:  BMJ       Date:  1999-12-11

2.  Tolcapone-related fulminant hepatitis: electron microscopy shows mitochondrial alterations.

Authors:  L Spahr; L Rubbia-Brandt; P R Burkhard; F Assal; A Hadengue
Journal:  Dig Dis Sci       Date:  2000-09       Impact factor: 3.199

3.  Herbalife hepatotoxicity: Evaluation of cases with positive reexposure tests.

Authors:  Rolf Teschke; Christian Frenzel; Johannes Schulze; Alexander Schwarzenboeck; Axel Eickhoff
Journal:  World J Hepatol       Date:  2013-07-27

Review 4.  Acute liver damage following intravenous glucocorticoid treatment for Graves' ophthalmopathy.

Authors:  Mariacarla Moleti; Giuseppe Giuffrida; Giacomo Sturniolo; Giovanni Squadrito; Alfredo Campennì; Silvia Morelli; Efisio Puxeddu; Eleonora Sisti; Francesco Trimarchi; Francesco Vermiglio; Michele Marinò
Journal:  Endocrine       Date:  2016-03-22       Impact factor: 3.633

5.  The natural history of histologically proved drug induced liver disease.

Authors:  P G Aithal; C P Day
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 6.  Drug-Induced Liver Injury: Why is the Roussel Uclaf Causality Assessment Method (RUCAM) Still Used 25 Years After Its Launch?

Authors:  Gaby Danan; Rolf Teschke
Journal:  Drug Saf       Date:  2018-08       Impact factor: 5.606

Review 7.  Drug and herb induced liver injury: Council for International Organizations of Medical Sciences scale for causality assessment.

Authors:  Rolf Teschke; Albrecht Wolff; Christian Frenzel; Alexander Schwarzenboeck; Johannes Schulze; Axel Eickhoff
Journal:  World J Hepatol       Date:  2014-01-27

Review 8.  Practical guidelines for diagnosis and early management of drug-induced liver injury.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

Review 9.  Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods.

Authors:  Rolf Teschke; Christian Frenzel; Johannes Schulze; Axel Eickhoff
Journal:  World J Gastroenterol       Date:  2013-05-21       Impact factor: 5.742

Review 10.  Causality assessment in hepatotoxicity by drugs and dietary supplements.

Authors:  Rolf Teschke; Alexander Schwarzenboeck; Karl-Heinz Hennermann
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.